Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Calevia Inc. to Develop Graphene-based, Non-Invasive Cancer Eradication Therapies in Partnership with Grafoid Inc. and ProScan Rx Pharma Inc.

Abstract:
ProScanRxPharma Inc. and Grafoid Inc announced today the formation of Calevia Inc., an entirely new cancer therapeutic nanotechnology platform for the precise targeting and thermal eradication of solid tumors.

Calevia Inc. to Develop Graphene-based, Non-Invasive Cancer Eradication Therapies in Partnership with Grafoid Inc. and ProScan Rx Pharma Inc.

Montreal, Canada | Posted on September 7th, 2013

Calevia intends to combine ProScan's cellular antibody targeting technologies with MesoGraf™Xide graphene supplied by Grafoid Inc. to eradicate cancerous cells in a non-invasive manner.

Mesograf™ Xide is a unique, functionalized, photoresponsive graphene material that may be coupled with ProScan' s selective molecular targeting antibody ligands to create a photothermal bio-conjugate for the treatment of prostate cancer. Grafoid's Mesograf™ derivative Mesograf™Xide is the latest development in thermal energy generating nanomaterial science that instantly transforms near infrared (NIR) light into heat.

As a result of targeting, the heat generating bio-conjugate is delivered selectively to tumor cells and remotely activated by harmless NIR light to safely and effectively destroy cancer tissue from within in a physically powerful way, heat. Calevia's targeted photothermal therapy may overcome the side effects and strong limitations of common therapeutic methods such as surgery, radiation and chemotherapy.

Focal therapy is the focus of significant development by the pharmaceutical industry. Calevia believes that photothermal therapy using heat as the treatment modality represents a very innovative approach to focal cancer treatment. Calevia will first target prostate cancer using Proscan's anti-PSMA antibody. The platform will be developed subsequently for several solid tumor types.

Dr Vezeau, co-founder of Calevia said the combination of cell targeting at the molecular level with Grafoid's MesoGraf™Xide could ultimately redefine the way medicine treats several forms of solid tumors. "That is our goal."

He added that Calevia's targeted photothermal treatment opens the door to an entirely new therapeutic platform that overcomes the deficiencies inherent in traditional therapies.

"Targeting the photothermal ablation of prostate and subsequently other solid cancers bridges the gap between conventional therapies and today's nanotechnology revolution," Dr. Vezeau said.

Calevia's co-founders Dr. Claude Vezeau serves as President and CEO, and Dr. Serge Moffett serves as Vice-President, Research and Development. Dr. Gordon Chiu, B.Sci., M.Sci., f-M.S.T.P., N.D. and Vice-President of Grafoid Inc., serves as co-manager and advisor to the project.

Grafoid Inc. has invested in Calevia Inc. and will co-manage the early stage venture. Grafoid is also involved with the arrangement of Calevia's next stage and longer-term financing.

Dr. Vezeau will be presenting Calevia at the Rodman & Renshaw Global Investment Conference in New York, September 8-10, 2013.

About ProScanRxPharma Inc.

ProScanRxPharma Inc. is an experienced developer of targeted monoclonal antibodies. ProScan is dedicated to the development of innovative solutions to improve and simplify the clinical management of patients suffering from prostate cancer. It applies modern technologies to develop new molecular tools to provide clinicians and their cancer patients with efficient diagnostic and treatment alternatives. ProScan's products are expected to bring a new wave of solutions to clinicians and patients for the safer and more efficient detection and control of prostate cancer.

About Grafoid Inc.

Grafoid Inc. is a privately held Canadian corporation investing in graphene applications and economically scalable production processes for MesoGraf™ - the global standard for graphene - and MesoGraf™Xide its trade mark graphene oxide produced from raw, unprocessed graphite ore. Focus Graphite Inc. (TSX VENTURE:FMS)(OTCQX:FCSMF)(FRANKFURT:FKC) holds a principal interest in Grafoid on behalf of its shareholders.

Forward Looking Statements - Disclaimer

This news release may contain forward looking statements, being statements which are not historical facts, and discussions of future plans and objectives. There can be no assurance that such statements will prove accurate. Such statements are necessarily based upon a number of estimates and assumptions that are subject to numerous risks and uncertainties that could cause actual results and future events to differ materially from those anticipated or projected.

####

For more information, please click here

Contacts:
ProScanRxPharma Inc.
Dr. Claude Vezeau
514-908-0660

www.proscanrxpharma.com
www.calevia.com

Grafoid Inc.
Dr. Gordon Chiu
Vice-President
613-691-1091 ext 104

www.grafoid.com

Copyright © Marketwire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Researchers develop artificial building blocks of life March 8th, 2024

How surface roughness influences the adhesion of soft materials: Research team discovers universal mechanism that leads to adhesion hysteresis in soft materials March 8th, 2024

Two-dimensional bimetallic selenium-containing metal-organic frameworks and their calcinated derivatives as electrocatalysts for overall water splitting March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

Graphene/ Graphite

First human trial shows ‘wonder’ material can be developed safely: A revolutionary nanomaterial with huge potential to tackle multiple global challenges could be developed further without acute risk to human health, research suggests February 16th, 2024

NRL discovers two-dimensional waveguides February 16th, 2024

$900,000 awarded to optimize graphene energy harvesting devices: The WoodNext Foundation's commitment to U of A physicist Paul Thibado will be used to develop sensor systems compatible with six different power sources January 12th, 2024

First direct imaging of small noble gas clusters at room temperature: Novel opportunities in quantum technology and condensed matter physics opened by noble gas atoms confined between graphene layers January 12th, 2024

Nanomedicine

High-tech 'paint' could spare patients repeated surgeries March 8th, 2024

Researchers develop artificial building blocks of life March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Announcements

What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

Events/Classes

Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023

CEA & Partners Present ‘Powerful Step Towards Industrialization’ Of Linear Si Quantum Dot Arrays Using FDSOI Material at VLSI Symposium: Invited paper reports 3-step characterization chain and resulting methodologies and metrics that accelerate learning, provide data on device pe June 17th, 2022

June Conference in Grenoble, France, to Explore Pathways to 6G Applications, Including ‘Internet of Senses’, Sustainability, Extended Reality & Digital Twin of Physical World: Organized by CEA-Leti, the Joint EuCNC and 6G Summit Sees Telecom Sector as an ‘Enabler for a Sustainabl June 1st, 2022

How a physicist aims to reduce the noise in quantum computing: NAU assistant professor Ryan Behunin received an NSF CAREER grant to study how to reduce the noise produced in the process of quantum computing, which will make it better and more practical April 1st, 2022

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project